The companies noted that, at 48 weeks, the novel investigational combination maintained a high rate (n=49; 94.2%) of viral ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

Alchemy, a developer of in-house pharmacy programs for clinics with large HIV and hepatitis C patient populations, raised $31 ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to ...

A man who identified himself as an HIV/AIDS advocate complained about the bad treatment they received from healthcare workers. “When we get there late, we are shouted at and they told that we ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years. Treatment for HIV/AIDS has consistently seen progress each decade ...

Lenacapavir is an important medication for HIV prevention and treatment. The agreement aims to bolster access to lenacapavir in 120 countries, with a particular focus on resource-limited nations that ...

Thanks to advancements in prevention and treatment, global HIV infection rates have dramatically declined in recent years. But HIV still affects over 38 million people around the world.

Dr. Reddy’s has been granted a non-exclusive voluntary licence to manufacture Lenacapavir and market it in 120 countries, for the current approved indication of HIV treatment in heavily ...

If there is an actual risk of transmission, the doctor may prescribe a 28-day course of HIV medications known as post-exposure prophylaxis (PEP). If started within 72 hours of a suspected exposure, ...